Latest Regulatory News

OncoSil Medical secures $8 million in capital to fund a pivotal German government-sponsored clinical trial and accelerate its European commercial expansion.

Verity Resources is raising approximately $2 million through a non-renounceable entitlement offer to advance its Monument Gold and Botswana copper-silver projects, with directors backing the move through participation and underwriting.

Little Green Pharma Ltd is set to acquire Cannatrek Ltd in a transformative merger that will create one of the largest vertically integrated medicinal cannabis companies globally, with pro-forma FY25 revenue exceeding AUD 112 million.

Atlas Arteria confirms the extension of France’s temporary supplemental tax into 2026 but maintains its 40 cents per share distribution guidance, signalling confidence amid regulatory shifts.

Aurora Energy Metals updates investors on its strategic option agreement with Eagle Energy Metals, which is set to become the first US-listed uranium explorer with SMR technology following a pending SPAC merger.

Acadia Pharmaceuticals has received a negative vote from the European Medicines Agency’s committee on its application to market trofinetide for Rett syndrome in the EU, prompting plans for a re-examination request.

Aguia Resources has successfully raised $5 million through a well-supported placement to fund key developments in its Colombian gold and Brazilian phosphate projects. The capital injection aims to boost production and strengthen the company's balance sheet.

Medallion Metals has obtained the crucial environmental green light under the EPBC Act for its Ravensthorpe Gold Project, significantly reducing permitting risks and positioning the company to advance its sulphide production plans.

Noronex Limited has exercised its option to acquire a 51% stake in the Etango North Uranium Project in Namibia, initiating a maiden drilling program backed by AI-driven exploration techniques.

Barton Gold Holdings has kicked off its 2026 drilling campaign at the Tunkillia Gold Project, aiming to secure Ore Reserves, complete a pre-feasibility study, and lodge a Mining Lease application by the end of the year.

Imricor Medical Systems has welcomed Oklahoma Heart Institute as the fourth U.S. site in its pivotal VISABL-AFL clinical trial, accelerating patient recruitment and the FDA approval pathway for its MRI-guided cardiac ablation technology.

Memphasys has lodged regulatory submissions for its Felix™ System in Australia and India, following CE Mark approval, while progressing UK market entry under the CE Mark transition framework.